ScholarLens Back to search
2013•International Journal of Radiation Oncology*Biology*PhysicsOpen access

Preclinical Evaluation of Genexol-PM, a Nanoparticle Formulation of Paclitaxel, as a Novel Radiosensitizer for the Treatment of Non-Small Cell Lung Cancer

Michael Edward Werner, Natalie D. Cummings, Manish Sethi, Edina C. Wang, Rohit Sukumar, Dominic T. Moore, Andrew Zhuang Wang

Open full text 268 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 268 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Radiosensitizer, Paclitaxel, Medicine, In vivo, Lung cancer, Pharmacology, Radiation therapy, Cancer research

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Preclinical Evaluation of Genexol-PM, a Nanoparticle Formulation of Paclitaxel, as a Novel Radiosensitizer for the Treatment of Non-Small Cell Lung Cancer — Research Paper | ScholarLens